Publications

Lyubchenko T, Berdyshev E, Weight RM, Xiao O, Shah NJ, Markova A, Lacouture ME, Kern JA, Goleva E, Leung DYM. Skin Abnormalities at Checkpoint Inhibitor Therapy Initiation Are Associated With Skin Rash Development in Oncology Patients. Allergy. 2026. PMID: 42500847

Krasnow NA, Salans M, Jayaraj M, Kuwahara K, Zhou MH, Boreta L, Braunstein SE, Aghi MK, Chien J, Rugo H, Melisko ME, Morshed RA, Vasudevan HN, Huppert LA. Clinical and molecular features of resected breast cancer brain metastases: a single center retrospective cohort study. Breast cancer research and treatment. 2026. PMID: 42474755

Balas J, Bowling L, Shakhnazaryan N, Aggarwal RR, Borno HT, Hong JC, Huang FW, Tong B, Kwon DH. Evaluation of an Artificial Intelligence Communication Platform for Racial Biases in Pretest Education About Prostate Cancer Germline Testing. JCO clinical cancer informatics. 2026. PMID: 42475635

Amouzegar A, Shaw R, Tsai KK, Olson D, Gibney GT. Stepping on the Gas or Hitting the Brakes: Response-Driven Therapy for Melanoma. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2026. PMID: 42462189

Schroers-Martin JG, Merryman R, Spinner MA, Yeung A, Chang C, Silin C, Powell M, Armand P, Shipp M, Advani R. Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma. Haematologica. 2026. PMID: 42389806

Lachowiez CA, Zeidner JF, Othman J, Kaempf A, Yun S, Heiblig M, Heuser M, Shahswar R, Madero Marroquin R, Cannova JM, Žucenka A, Marvin-Peek J, Senapati J, Abaza Y, Swaroop A, Zacheo I, Monaco F, Belhabri A, Tauveron-Jalenques U, Tavernier E, Carré M, Aspas Requena G, Cook RJ, Traer E, Saultz JN, O'Nions J, Basheer F, Laurie J, Handa S, Stein EM, Baer MR, Olin R, Blum W, Schiller G, Lin T, Curran E, Yocum A, Madarang E, Daver N, Kadia TM, Marconi G, Madanat Y, Dillon R, DiNardo CD, Swords R, Arango Ossa JE, Watts J, Loghavi S, Pollyea DA, Bernard E, PRISM-AML Investigators. Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026. PMID: 42391582

Hoff FW, Zeidner JF, Torlapati G, Nicolet D, Mrózek K, Huang Y, Li A, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike O, Olin RL, Smith CC, Schiller GJ, Curran EK, Chan O, McMahon C, Hochman M, Sahasrabudhe K, Foucar C, Gonzalez-Lugo J, Knick Ragon B, Handa SV, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Eisfeld AK, Byrd JC, Madanat YF. Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA. American journal of hematology. 2026. PMID: 42393840

Reyes KR, Zhu R, Herberts C, Dutta P, Wray A, Mitchell B, Balkhi SS, Zhu X, Chu CE, Porten SP, Friedlander TW, Chou J, Seyedin SN, Sharma S, Malhotra M, ElNaggar AC, Liu MC, Ayanambakkam A, Koshkin VS. Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab. European urology oncology. 2026. PMID: 42379901

Silverstein JF, Huppert LA, Schwede M, Goglin S, Johnson TP, Babik JM, Brondfield S. Optimizing a Hematology/Oncology Curriculum for Internal Medicine Residents: A Two-Institution Modified Delphi Study. Journal of cancer education : the official journal of the American Association for Cancer Education. 2026. PMID: 42380386

Mohanty A, Stead AE, Telep LE, Singer AW, Curteis T, Zolotor A, Frenette C, Khoshabafard D, Hammond K, McQuaid T, Kelley RK. Hepatocellular carcinoma risk reduction associated with antiviral treatment in patients with noncirrhotic chronic hepatitis B: a systematic literature review and comparative meta-analysis. BMC gastroenterology. 2026. PMID: 42363070

Desai SH, Geyer SM, Pederson L, Spinner MA, Bachanova V, Evens AM, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Chang C, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Wagner-Johnston N, Jagadeesh D, Blum KA, Diefenbach C, Iyengar S, Rappazzo KC, Baidoun F, Choi Y, Advani RH, Mocikova H, Sykorova A, Michalka J, Prochazka V, Micallef IN. Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma. Blood cancer journal. 2026. PMID: 42343091

Aggarwal R, Ruff CT, Palazzolo MG, Büttner FC, Pieper K, Eikelboom J, Patel M, Granger CB, Wallentin L, Hijazi Z, Virdone S, Zimetbaum P, Secemsky EA, Kakkar AK, Giugliano RP, Yeh RW. DOAC score among patients receiving Vitamin K antagonists. American heart journal. 2026. PMID: 42336120

Trudeau J, Thati N, Ng DQ, Chavez-Iglesias E, Olshen AB, Dhruva A, Chan JW, Chan RJ, Chan A, Kober KM. Distinct neuronal, proliferative, and secretory pathways are perturbed in cancer survivors with depressive symptoms. medRxiv : the preprint server for health sciences. 2026. PMID: 42369470

Lombardi P, Ramon-Gil E, Raja RQ, Brunetti L, Manfredi GF, Zhou Z, Merces G, Cappuyns S, Fulgenzi CAM, D'Alessio A, Torkpour A, Celsa C, Stefanini B, Yang H, Crowley F, Marron TU, Saeed A, Pinter M, Scheiner B, Huang YH, Lee PC, Nishida N, Po-Ting Lin R, Dalbeni A, Vivaldi C, Masi G, Rohlen N, von Felden J, Kaseb A, Galle PR, Kudo M, Hsu WF, Rimassa L, Parisi A, Kelley RK, Toyoda H, Pirisi M, Jabar F, Rakaee M, Cabibbo G, Cammà C, Piscaglia F, Hwang S, Shin DJ, Li M, Dekervel J, Guerra N, Meyer T, Reeves HL, Bengsch B, Daniele G, Mann DA, Chon HJ, Leslie J, Pinato DJ. A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma. Journal of hepatology. 2026. PMID: 42297215

Zwart K, van Kruijsdijk RCM, Nagtegaal ID, Bol GM. Reply to "Reassessing the evidence for elevated deficient mismatch repair colorectal cancer risk after kidney transplantation". American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2026. PMID: 42269873

Kimambo AH, Vuhahula E, Mmbaga EJ, Baraka BM, Malango A, Illonga Z, Mushi BP, Kitosho B, Van Loon K, Ng DL. Contextual Barriers and Facilitators to Implementing Ultrasound-Guided Fine-Needle Aspiration and Rapid Onsite Evaluation in a Resource-Limited Setting. JCO global oncology. 2026. PMID: 42269133

Llovet JM, Mauro E, Rimassa L, Mazzaferro V, Pinter M, Kelley RK, Chan SL, Kulik L, Pillai A, Roberts L, Sangro B, Casanovas T, Kaplan DE, Vogel A, Yarchoan M, Finn RS, Meyer T, Singal AG. Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement. Nature reviews. Clinical oncology. 2026. PMID: 42270817

Zeng J, Cheng Z, Chen H, Wang Z, Thompson J, Crosby KT, Han H, Singhal A, Ngo W, Xia C, Rosas-Rivera D, Zhang Z, Kang MH, Mao Y, Diolaiti ME, Lee GC, Diffley JFX, Song Y, Qiu L, Krah NM, Murthy N, Jackson RN, Liu Y, Ashworth A, Doudna JA. Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding. Nature. 2026. PMID: 42259916

Gu D, Cuby J, Gomez O, Mark H, Hall S, Stitzer M, Kushel M, Vijayaraghavan M. Money Helps: Financial Incentives for Smoking Cessation Among People Experiencing Homelessness. Substance use & misuse. 2026. PMID: 42246249

Wong P, Pollini T, Hernandez S, Tao S, Qiao G, Amouzegar A, Bol GM, Daud AI, Tao DL, Tsai KK, Lee J, Maker AV. The paradox of escalating immunotherapy for uveal melanoma liver metastases. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2026. PMID: 42315386